Medical abortion in the first trimester

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 16, Issue 2, 2002, Pages 221-236

  Baird, David T ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Medical abortion; Mifepristone; Prostaglandins

Indexed keywords

ANTIMETABOLITE; EPOSTANE; GEMEPROST; METHOTREXATE; MIFEPRISTONE; MISOPROSTOL; PROSTAGLANDIN; SULPROSTONE; UTEROTONIC AGENT; ABORTIVE AGENT;

ABORTION; CLINICAL PROTOCOL; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; EUROPE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HUMAN; LICENCE; NAUSEA AND VOMITING; PAIN; PARITY; PNEUMONIA; PREGNANCY; PRIORITY JOURNAL; REVIEW; TREATMENT FAILURE; UNITED STATES; UTERUS; UTERUS CONTRACTION; VACUUM ASPIRATION; VOMITING; CHEMISTRY; DRUG COMBINATION; FEMALE; INDUCED ABORTION; METHODOLOGY; TREATMENT OUTCOME;

ABORTIFACIENT AGENTS; ABORTION, INDUCED; CLINICAL PROTOCOLS; DRUG COMBINATIONS; FEMALE; HUMANS; MIFEPRISTONE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROSTAGLANDINS; TREATMENT OUTCOME;

EID: 0036528498     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1053/beog.2001.0272     Document Type: Article

References (87)

1. Segal ST & LaGuardia KD. Termination of pregnancy - a global view. Bailliere's Clinical Obstetrics and Gynaecology 1990; 4: 235-247.
2. Van Look PFA & Von Hertzen H. Induced abortion: a global perspective. In Baird DT, Grimes DA & Van Look PFA (eds) Modern Methods of Inducing Abortion, pp 1-24. Oxford: Blackwell Science, 1995.
3. Bygdeman M, Gemzell-Daniellson K, Marions L & Swahn M-L. Pregnancy termination. Steroids 2000; 65: 801-805.
4. Baird DT, Grimes DA & Van Look PFA. Modern Methods of Inducing Abortion. Oxford: Blackwell Science.
5. Cates W, Schulz KF, Grimes DA & Tyler CW. Short term complications of uterine evacuation techniques for abortion at 12 weeks gestation or earlier. In Zatuchi GI et al (eds) Pregnancy Termination - Procedures, Safety and New Developments, pp 127-135. New York: Harper & Row, 1979.
6. WHO Medical methods for termination of pregnancy. WHO Technical Report Series, 871. Geneva: World Health Organization, 1997.
7. Royal College of Obstetricians and Gynaecologists. The care of women requesting induced abortion. Evidence Based Guidelines No 7. London: RCOG Press, 2000.
8. Early Medical Abortion. American Journal of Obstetrics and Gynecology 2000; Suppl 183: 51-594.
9. Early Medical Abortion, journal of the American Women's Association 2000; Suppl Vol 55: 115-204.
10. Kahn JG, Becker BJ, MacIsaa L et al. The efficacy of medical abortion: A meta-analysis. Contraception 2000; 61: 29-40.
11. Baird DT. Overview of abortion techniques. In Baird DT, Grimes DA & Van Look PFA (eds) Modern Methods of Inducing Abortion, pp 25-38. Oxford: Blackwell Science, 1995.
12. Karim SMM & Filshie GM. Therapeutic abortion using prostaglandin F2 α. Lancet 1970; 157-159.
13. Bygdeman M. Menstrual regulation with prostaglandins. In Karim SMM (ed.) Practical Applications of Prostaglandins and their Synthesis Inhibitors, pp 267-282. Lancaster: MTP Press Ltd, 1979.
14. Ulmann A, Teusch G & Philibert D. RU486. Scientific American 1990; 262: 18-24.
15. Herrman W, Wyss R & Riondel A. Effet d'un stéroid antiprogesterone chez la femme: Interruption du cycle menstrual et de la grossesse au débit. Comptes Rendus de L'Academie des Sciences 1982; 294: 933-938.
16. Baird DT & Thong KJ. Advances in methods of inducing abortion. In Otteson B & Tabor A (eds) New Insights in Gynecology and Obstetrics Research and Practice. Proceedings of XV FIGO World Congress of Gynaecology and Obstetrics, Copenhagen, pp 193-200. Carnforth, UK: Parthenon Publishing, 1998.
17. Sitruk-Ware R. Approval of mifepristone (RU486) in Europe. Zentralblatt für Gynakologi 2000; 122: 241-247.
18. Bygdeman M & Green KK. Menstrual regulation: Medicine techniques. In Zatuchni GI, Sciarra JJ & Spiedel JJ (eds) Pregnancy Termination: Procedures, Safety and New Developments, pp 69-77. Harper & Row, 1979.
19. Bleyer WA. Clinical pharmacology of methotrexate: New applications of an old drug. Cancer 1978; 41: 36-51.
20. Baird DT. Mode of action of medical methods of abortion. Journal of the American Medical Women's Association 2000; 55: 121-126.
21. van der Spuy ZM, Jones DC, Wright CSW et al. Inhibition of 3βhydroxy steroid dehydrogenase activity in first trimester human pregnancy with Trilostane and WIN 32729. Clinical Endocrinology 1983; 19: 521-532.
22. Webster MA, Pattison NS, Phipps SL & Gillmer MDG. Myometrial activity in first trimester human pregnancy after Epostane therapy: the effect of intravenous oxytocin. British Journal of Obstetrics and Gynaecology 1985; 92: 957-962.
23. Webster MA, Phipps SL & Gillmer MDG. Interruption of first trimester human pregnancy following Epostane therapy. Effect of prostaglandin E2 pessaries. British Journal of Obstetrics and Gynaecology 1985; 92: 963-968.
24. Spitz IM & Bardin CW. RU486 - A modulator of progeston and glucocorticoid action. New England Journal of Medicine 1993; 329: 404-412.
25. Allan GF, Leng XH, Tsai SY et al. Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. Journal of Biological Chemistry 1992; 267: 19513-19520.
26. Spitz IM & Chwalisz K. Progesterone receptor modulators and progesterone antagonists in women's health. Steroids 2000; 65: 807-815.
27. Norman TE, Wu WX, Kelly RW et al. Effects of mifepristone in vitro on decidual prostaglandin synthesis and metabolism. Contraception 1991; 44: 89-98.
28. Cheng L, Kelly RW, Thong KJ et al. The effects of mifepristone (RU486) on prostaglandin dehydrogenase in decidual and chorionic tissue in early pregnancy. Human Reproduction 1993; 8: 705-709.
29. Bydgeman M & Swahn M-L. Progesterone receptor blockage: effect on uterine contractility and early pregnancy. Contraception 1985; 32: 45-51.
30. Critchley HOD, Kelly RW, Lea RG et al. Sex steroid regulation of leucocyte traffic in human decidua. Human Reproduction 1996; 11: 2257-2262.
31. Henshaw RC & Templeton AA. Pre-operative cervical preparation before first trimester vacuum aspiration: a randomized controlled comparison between gemeprost and mifepristone (RU486). British Journal of Obstetrics and Gynaecology 1991; 98: 1025-1030.
32. Denison FC, Riley SC, Elliot CL et al. The effect of mifepristone administration on leucocyte populations, matrix metalloproteinases and inflammatory mediators in the first trimester cervix. Molecular Human Reproduction 2000; 6: 541-548.
33. Ragab J & Edelman D. Early termination of pregnancy. A comparative study of intrauterine prostaglandin F2α and vacuum aspiration. Prostaglandins 1976; 11: 275-283.
34. Smith SK & Baird DT. The use of 16, 16 dimethyl-transΔ2-PGE, methyl ester (ON0802) vaginal suppositories for the termination of early pregnancy: A comparative study. British Journal of Obstetrics and Gynaecology 1980; 87: 712-727.
35. Lundstrom V, Bygdeman M, Fotiou S et al. Abortion in early pregnancy by vaginal administration of 16, 16-dimethyl PGE2 in comparison with vacuum aspiration. Contraception 1977; 16: 176-173.
36. WHO Task Force on Post-ovulatory Methods for Fertility Regulation. Menstrual regulation by intramuscular injections of 16-phenoxytetranor PGE2 methyl sulfonylamide or vacuum aspiration. British Journal of Obstetrics and Gynaecology 1987; 94: 949-956.
37. Gonzales CH, Vargas R, Perez ABA et al. Limb deficiency with or without Mobius sequence in seven Brazilian children associated with misoprostol use in the first trimester of pregnancy. American Journal of Medicine Genetics 1993; 47: 49-64.
38. Carbonell JLL, Varela L, Velazco A & Fernandez C. The use of misoprostol for termination of early pregnancy. Contraception 1997; 55: 165-168.
39. Blanchard K, Winikoff B & Ellertson C. Misoprostol used alone for the termination of early pregnancies: a review of the evidence. Contraception 1999; 59: 209-217.
40. Bugalho A, Mucumbi S, Faundes A & David E. Termination of pregnancies at < 6 week gestation with a single dose of 800 mg of vaginal misoprostol. Contraception 2000; 61: 47-50.
41. Creinin MD & Darney PD. Methotrexate and misoprostol for early abortion. Contraception 1993; 48: 339-348.
42. Wiebe ER. Abortion induced with methotrexate and misoprostol: A comparison of various protocols. Contraception 1997; 55: 159-163.
43. Darab DJ, Minkoff R, Sciote J & Sulik KK. Pathogenesis of median facial clefts in mice treated with methotrexate. Teratology 1978; 36: 77-86.
44. Birgerson L, Olund A, Odlind V & Somell C. Termination of early human pregnancy with epostane. Contraception 1987; 35: 111-120.
45. Crooij MJ, Coenraad CA, de Nooyer B et al. Termination of early pregnancy by the 3βhydroxysteroid dehydrogenase inhibitor epostane. New England Journal of Medicine 1988; 319: 813-828.
46. Couzinet B, Strat NL, Ulmann A et al. Termination of early pregnancy by the progesterone antagonist RU486 (mifepristone). New England Journal of Medicine 1986; 315: 1565-1570.
47. Kovacs L, Sas M, Resch BA et al. Termination of very early pregnancy by RU486 - an antiprogestational compound. Contraception 1984; 29: 399-410.
48. Cameron IT, Michie AF & Baird DT. Therapeutic abortion in early pregnancy with antiprogestogen RU 486 alone or in combination with prostaglandin analogue (Gemeprost). Contraception 1986; 34: 459-467.
49. Rodger MW & Baird DT. Induction of therapeutic abortion in early pregnancy with the antigestogen RU486 in combination with a prostaglandin pessary (gemeprost). Lancet 1987; 11: 1415-1418.
50. World Health Organization. Pregnancy termination with mifepristone (RU486) and gemeprost: A multicentre comparison between repeated doses and a single dose of mifepristone. Fertility and Sterility 1991; 56: 32-40.
51. UK Multicentre Trial. The efficacy and tolerance of mifepristone and prostaglandin in first trimester pregnancy. British Journal of Obstetrics and Gynaecology 1990; 97: 480-486.
52. UK Multicentre Study-Final Results. The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation. Contraception 1997; 55: 1-5.
53. Ulmann A, Silvestre L, Chemama L et al. Medical termination of early pregnancy with mifepristone (RU486) followed by a prostaglandin analogue. Acta Obstetricia et Gynecologica Scandinavica 1992; 71: 278-283.
54. Anon. A death associated with mifepristone/sulprostone. Lancet 1991; 337: 969-970.
55. Ashok PW, Flett GM & Templeton AA. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol. Lancet 1998; 352: 542-543.
56. Schaff EA & Fielding SL. A comparison of the abortion rights mobilization and population council trials. Journal of the American Medical Women's Association 2000; 55: 137-140.
57. Thong KJ, Dewar M & Baird DT. What do women want during a medical abortion? Contraception 1992; 46: 435-442.
58. Rodger MW & Baird DT. Blood loss following induction of early abortion using mifepristone (RU486) and a prostaglandin analogue (Gemeprost). Contraception 1989; 40: 439-447.
59. Cameron ST, Glasier AF, Logan J et al. Impact of the introduction of new medical methods on therapeutic abortions at the Royal Infirmary of Edinburgh. British Journal of Obstetrics and Gynaecology 1996; 103: 1222-1229.
60. Martin CW, Brown A & Baird DT. A pilot study of the effect of methotrexate or combined oral contraceptive on bleeding patterns after induction of abortion with mifepristone and a prostaglandin pessary. Contraception 1998; 58: 99-103.
61. Tang OS, Gao PP, Cheng L et al. Randomised double-blind placebo controlled study to assess the effect of oral contraceptive pills on the outcome of medical abortion with mifepristone and misoprostol. Human Reproduction 1999; 14: 722-725.
62. Cameron IT & Baird DT. Early pregnancy termination: a comparison between vacuum aspiration and medical abortion using prostaglandin (16, 16-dimethyl-trans-Δ2-PGE, methyl ester) or the antigestogen RU486. British Journal of Obstetrics and Gynaecology 1988; 95: 271-276.
63. Child TJ, Thomas J, Rees M & MacKenzie IZ. A comparative study of surgical and medical procedures: 932 pregnancy terminations up to 63 days gestation. Human Reproduction 2001; 16: 67-71.
64. Henshaw RC, Naji SA, Russell IT & Templeton AA. Comparison of medical abortion with surgical vacuum aspiration: women's perspectives and acceptability of treatment. British Medical Journal 1993; 307: 714-717.
65. Bachelot A, Cludy L & Spira A. Conditions for choosing between drug-induced and surgical abortions. Contraception 1992; 45: 547-559.
66. Winikoff B, Elertson C, Elul B & Sivin I. Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol. Results of a large multicentre trial in the United States. Archives of Family Medicine 1998; 7: 360-366.
67. Peyron R, Aubeny E, Targosz V et al. Early termination of pregnancy with mifepristone (RU486) and the orally active prostaglandin misoprostol. New England Journal of Medicine 1993; 21: 1509-1513.
68. Spitz IM, Bardin CW, Benton L & Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. New England Journal of Medicine 1998; 338: 1241-1247.
69. Norman JE, Thong KJ, Rodger MW & Baird DT. Medical abortion in women at < 56 days amenorrhoea: a comparison between gemeprost (a PGEI analogue) alone and mifepristone and gemeprost. British Journal of Obstetrics and Gynaecology 1992; 99: 601-606.
70. WHO Task Force on Post-ovulatory Methods of Fertility Regulation. Termination of pregnancy with reduced doses of mifepristone. British Medical Journal 1993; 307: 532-536.
71. McKinley C, Thong KJ & Baird DT. The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol. Human Reproduction 1993; 8: 1502-1505.
72. Ashok PW, Penney GC, Flett GMM & Templeton A. An effective regime for early medical abortion: a report of 2000 consecutive cases. Human Reproduction 1998; 13: 2962-2965.
73. Bartley J, Tong S, Everington D & Baird DT. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost. Contraception 2000; 62: 297-303.
74. Sang G, Weng L, Shao Q et al. Termination of early pregnancy by two regimens of mifepristone with misoprostol and mifepristone with PG05-a multicentre randomised clinical trial in China. Contraception 1994; 50: 501-505.
75. WHO Task Force on Post-ovulatory Methods in Fertility Regulation. Lowering doses of mifepristone and gemeprost for early abortion : a randomised controlled trial. BJOF 2001; 103: 738-742.
76. Aubeny E, Peyron R, Turpin C et al. Termination of early pregnancy (up to and after 63 days of amenorrhoea) with mifepristone (RU 486) and increasing doses of misoprostol. International Journal of Fertility 1995; 40 (suppl 2): 85-91.
77. Baird DT, Sukchareon N & Thong KJ. Randomised trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion. Human Reproduction 1995; 10: 1521-1527.
78. El-Rafaey H, Rajasekar D, Abdalla M et al. Induction of abortion with mifepristone (RU486) and oral or vaginal misoprostol. New England Journal of Medicine 1995; 332: 983-987.
79. Rodger MW, Logan AF & Baird DT. Induction of early abortion with mifepristone (RU486) and two different doses of prostaglandin pessary (gemeprost). Contraception 1989; 39: 497-502.
80. Bartley J, Brown A, Elton R & Baird DT. A double blind randomised control trial between vaginal gemeprost and misoprostol in combination with mifepristone for induction of abortion in early pregnancy. Human Reproduction 2001; 16: 2098-2102.
81. Sitruk-Ware R, Davey A & Sakiz E. Fetal malformation and failed medical terminations of pregnancy. Lancet 1998; 352: 323.
82. Zieman M, Fong SK, Benowitz NL et al. Absorption kinetics of misoprostol with oral or vaginal administration. Obstetrics and Gynaecology 1997; 44: 353-360.
83. 2-PGE. Prostaglandins 1983; 25: 225-235.
84. WHO. Menstrual regulation by mifepristone plus prostaglandin: results from a multicentre trial. Human Reproduction 1995; 10: 308-314.
85. Wu S. Medical abortion in China. Journal of the American Medical Women's Association 2000; 55: 197-199.
86. Bygdeman M, Gemzell-Daniellson K & Marions L. Medical termination in early pregnancy: The Swedish experience. Journal of the American Medical Women's Association 2000; 55: 195-196.
87. Glasier A & Thong JK. The establishment of a centralised referral service leads to earlier abortion. Health Bulletin 1991; 49: 254-259.